Your browser doesn't support javascript.
loading
CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
Pedersen, Martin H; Hood, Brian L; Ehmsen, Sidse; Beck, Hans C; Conrads, Thomas P; Bak, Martin; Ditzel, Henrik J; Leth-Larsen, Rikke.
Afiliação
  • Pedersen MH; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Hood BL; Womens Health Integrated Research Center at Inova Health System; Gynecologic Cancer Center of Excellence, Henry Jackson Foundation for the Advancement of Military Medicine, Annandale, VA.
  • Ehmsen S; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
  • Beck HC; Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark.
  • Conrads TP; Womens Health Integrated Research Center at Inova Health System; Gynecologic Cancer Center of Excellence, Henry Jackson Foundation for the Advancement of Military Medicine, Annandale, VA.
  • Bak M; Inova Schar Cancer Institute, Inova Center for Personalized Health, Fairfax, VA.
  • Ditzel HJ; Department of Pathology, Odense University Hospital, Odense, Denmark.
  • Leth-Larsen R; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Int J Cancer ; 144(3): 631-640, 2019 02 01.
Article em En | MEDLINE | ID: mdl-30110125
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / NADPH-Ferri-Hemoproteína Redutase / Neoplasias de Mama Triplo Negativas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / NADPH-Ferri-Hemoproteína Redutase / Neoplasias de Mama Triplo Negativas Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2019 Tipo de documento: Article